DLGAP1 and central nervous system cancer: In both primary and recurrent gliomas, compared with the lowly expressed DLGAP1-AS1 group, the OS time of patients in the highly expressed DLGAP1-AS1 group was greatly shorter by analyzing the CGGA database (Figures 5(a) and 5(b)).